@drmichaelmarks.bsky.social
NIHR Research Professor Professor of Medicine at LSHTM. Lead for Integrated Academic Training at LSHTM. Consultant in Infectious Diseases at UCLH. Syphilis & STIs, Neglected Tropical Diseases, Emerging Infectious Diseases, Group A Strep, Pragmatic Trials
@drmichaelmarks.bsky.socialThere is a good study by Lorenzo Giacani pubmed.ncbi.nlm.nih.gov/39067061/ showing that long term sub-therapeutic exposure with in-vitro culture model didn't lead to resistance.
Its will be challenging to monitor given that we will be reliant on technically difficult genomic approaches to do this.
@nicolelieberman.bsky.socialReposted by @drmichaelmarks.bsky.socialAmazing scientific opportunities working on cutting-edge microscopy and cell biology to understand T pallidum pathogenesis, working with my dear friend and colleague Linda Grillova at LSHTM.
@iddjobs.orgReposted by @drmichaelmarks.bsky.socialCLOSING SOON: PhD position (Bristol, UK)
Modelling the impact of homelessness and related social exclusions on health in the UK
with Jack Stone, Peter Vickerman, Ian Thomas
at University of Bristol
More details: http://iddjobs.org/jobs/2590
@petermacp.bsky.socialReposted by @drmichaelmarks.bsky.socialWe have two major papers out, showing:
1) A new way to measure #TB at local level with convenience sampling & IGRA testing journals.plos.org/globalpublic...
2) Targeted case finding using this approach identifies more TB, reduce DALYs & improve cost-effectiveness journals.plos.org/plosmedicine...
@drmichaelmarks.bsky.socialInfectious Diseases Academic Clinical Fellow posts in London open for applications.
Posts @lshtm.bsky.social @qmul.bsky.social & @ucl.ac.uk
Open to people who are eligible to start at IMT3/ST3/4 in Core Infection Training.
Deadline 29th October
If considering the LSHTM post do get in touch.
@geneticscam.bsky.socialReposted by @drmichaelmarks.bsky.socialš We're Hiring!
The Department of Genetics is seeking an Assistant/Associate Professor in Pathogen Genetics.
This is an exciting opportunity to contribute to teaching excellence, and join our world leading community in Genetics.
š¢ Apply www.cam.ac.uk/jobs/assista...
@drmichaelmarks.bsky.socialLondon Launchpad scheme now open. Provides funding for clinical academics inc doctors, nurses & allied health professionals. Must be within 3yrs (pro rata) of doctorate. Will provide funding to support researchers from discovery through to early translation. Deadline 5pm 26th October 2026.
@drmichaelmarks.bsky.socialThanks @benvyle.bsky.social for hosting us @thelovetankcic.bsky.social to discuss community co-creation, participation, engagement and qualitative research as part of out collaborative projects focused on the control of syphilis in the UK.
@gpollara.bsky.socialReposted by @drmichaelmarks.bsky.socialšØ NEW RESEARCH TECHNICIAN POST šØ
š Interested in understanding the biology of recurrent UTI?
š Keen to work in my own and @jennyrohn.bsky.social research groups at UCL?
Then please do take a look at new position available š. Informal enquiries encouraged.
#UTISky
@drmichaelmarks.bsky.socialCongratulations. Richly deserved. Hope we can setup new collaborations as you move to the new post!
@drmichaelmarks.bsky.socialPleased to announce our collaboration @lshtm.bsky.social & Pan-American Health Organization Series tackles key issues in Syphilis inc. diagnosis, treatment, linkage, key populations & management in pregnancy. Pulled together by @joetucker.bsky.social! Available in English, Spanish & Portuguese
@drmichaelmarks.bsky.socialApplications closing this week. Looking for a mathematical modeller to come and work on STI modelling @lshtm.bsky.social - 3yr funded post-doc. @sbfnk.bsky.social @rozeggo.bsky.social @nicolamlow.bsky.social @drlouisedyson.bsky.social @cmmid-lshtm.bsky.social @thomrawson.bsky.social @banks.ac
@brennankahan.bsky.socialReposted by @drmichaelmarks.bsky.social***JOB ALERT***
We are seeking to appoint 3 Statistical Methodologists to work on methods related to the statistical analysis of clinical trials, or innovative design methodology.
The posts will be based within the UCL Institute of Clinical Trials and Methodology.
@drtoniho.bsky.socialReposted by @drmichaelmarks.bsky.socialSee details of 2 #PhD posts based at CVR & 12 other projects based in Finland, Denmark, Netherlandsx Spain & England through the DETECTIVE MSCA Doctoral Network š¦ šµļøāāļø š
@drmichaelmarks.bsky.socialIn October we are hosting an open-evening on academic infectious diseases training in London. ACF posts open to people who have/will completed IMT. ACL posts for those who completed a PhD & in general already hold NTN in Infectious Diseases. If interested in attending sign-up using the link.
@drmichaelmarks.bsky.socialCare was close to the community so we were treating cases early & outcomes were good. Nested acceptability & health economic evaluations coming soon. Work led by a great team of Ethiopian colleagues from the Armauer Hansen Research Institute & @lshtm.bsky.social. Funding from @nihr.bsky.social
@drmichaelmarks.bsky.socialWe deployed CO2 cryotherapy at a health centre and trained the staff to make a parasitological diagnosis of CL and deliver CO2 cryotherapy. We found ~2/3 individuals with CL could be treated at the local health facility using this model. Most people received 4-6 rounds of cryotherapy.
@drmichaelmarks.bsky.socialCutaneous leishmaniasis is a major problem in Ethiopia & often requires admission for systemic therapy. Liquid nitrogen cryotherapy is an option but also has significant logistic barriers. We evaluated leveraging CO2 cryotherapy deployed for cervical cancer to decenteralise treatment for CL.
@drmichaelmarks.bsky.socialReposted by @drmichaelmarks.bsky.socialStill 1 week to apply. Looking for a great mathematical modeller to come and do a post-doc @lshtm.bsky.social focused on STI modelling in the UK.
@drmichaelmarks.bsky.socialThere are some beta lactamases such as some TEMs as well as efflux pump mediated resistance mechanisms too I believe where isolate can be Co-Amox Res but Pip-Taz sens so these represent a clear non Pseud indication too.
